Bojan Jelaković

22.4k total citations · 1 hit paper
141 papers, 1.6k citations indexed

About

Bojan Jelaković is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, Bojan Jelaković has authored 141 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cardiology and Cardiovascular Medicine, 28 papers in Radiology, Nuclear Medicine and Imaging and 24 papers in Nephrology. Recurrent topics in Bojan Jelaković's work include Blood Pressure and Hypertension Studies (35 papers), Nephrotoxicity and Medicinal Plants (27 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Bojan Jelaković is often cited by papers focused on Blood Pressure and Hypertension Studies (35 papers), Nephrotoxicity and Medicinal Plants (27 papers) and Drug-Induced Hepatotoxicity and Protection (10 papers). Bojan Jelaković collaborates with scholars based in Croatia, United States and Serbia. Bojan Jelaković's co-authors include Arthur P. Grollman, Neda Slade, Branko Brdar, Robert J. Turesky, Frederick W. Miller, Zvonimir Medverec, Masaaki Moriya, Andrea Fernandes, Lin Wu and Thomas A. Rosenquist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Bojan Jelaković

118 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aristolochic acid and the etiology of endemic (Balkan) nephropathy

2007 448 citations Arthur P. Grollman, Shinya Shibutani et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bojan Jelaković Croatia	15	881	565	413	192	168	141	1.6k
Max Dratwa Belgium	21	607 0.7×	519 0.9×	283 0.7×	221 1.2×	80 0.5×	101	2.0k
Jean‐Louis Vanherweghem Belgium	28	1.0k 1.2×	818 1.4×	390 0.9×	134 0.7×	114 0.7×	84	2.3k
Joëlle Nortier Belgium	32	2.4k 2.8×	1.9k 3.3×	946 2.3×	519 2.7×	90 0.5×	140	4.6k
C. Richard France	4	644 0.7×	531 0.9×	281 0.7×	66 0.3×	25 0.1×	8	944
Jean-Louis Vanherweghem Belgium	6	428 0.5×	309 0.5×	174 0.4×	47 0.2×	21 0.1×	8	780
Dominique Vandervelde Belgium	5	599 0.7×	495 0.9×	260 0.6×	95 0.5×	11 0.1×	5	925
Xiao Chen China	20	205 0.2×	119 0.2×	59 0.1×	244 1.3×	28 0.2×	105	1.3k
J L Vanherweghem Belgium	12	361 0.4×	301 0.5×	122 0.3×	41 0.2×	40 0.2×	27	893
D. Verbeelen Belgium	4	618 0.7×	502 0.9×	261 0.6×	68 0.4×	7 0.0×	9	894
Yu Xia China	21	123 0.1×	48 0.1×	47 0.1×	332 1.7×	49 0.3×	89	1.4k

Countries citing papers authored by Bojan Jelaković

Since Specialization

Citations

This map shows the geographic impact of Bojan Jelaković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bojan Jelaković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bojan Jelaković more than expected).

Fields of papers citing papers by Bojan Jelaković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bojan Jelaković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bojan Jelaković. The network helps show where Bojan Jelaković may publish in the future.

Co-authorship network of co-authors of Bojan Jelaković

This figure shows the co-authorship network connecting the top 25 collaborators of Bojan Jelaković. A scholar is included among the top collaborators of Bojan Jelaković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bojan Jelaković. Bojan Jelaković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jurić, Ivana, et al.. (2024). Combination of SGLT2 Inhibitors and GLP-1 Receptor Agonists in PTDM Treatment in Kidney Transplant Recipients: Synergistic Effect With Added Value in Terms of Nephroprotection. Transplantation Proceedings. 56(6). 1264–1265. 4 indexed citations

Hitij, Jana Brguljan, Zbigniew Gaciong, Dragan Šimić, et al.. (2024). Differences in sex and age response to single pill combination based antihypertensive therapy reflecting in blood pressure and arterial stiffness. Journal of Hypertension. 43(3). 387–396.

Jurić, Ivana, et al.. (2024). Immunomodulatory Effect of COVID-19 on HLA-Antibody Profile in Renal Transplant Recipients. Journal of Clinical Medicine. 13(8). 2383–2383. 1 indexed citations

Glavić, Mihaela Marinović, et al.. (2024). BLOOD PRESSURE MEASUREMENTS IN COMMUNITY PHARMACIES IS STILL UNDERSUED IN CROATIA. Journal of Hypertension. 42(Suppl 1). e65–e65.

Jelaković, Bojan, et al.. (2024). PREVALENCE AND CONTROL OF ARTERIAL HYPERTENSION AMONG PATIENTS WITH GLOMERULAR DISEASES. Journal of Hypertension. 42(Suppl 1). e211–e212.

Jurić, Ivana, et al.. (2024). A Comparative Analysis of the SARC-F Questionnaire and the Malnutrition–Inflammation Score for Sarcopenia Risk Assessment and Negative Outcome Probability in Chronic Hemodialysis Patients. Journal of Clinical Medicine. 13(18). 5554–5554. 1 indexed citations

Knežević, Tamara, et al.. (2023). #6873 HEPATOCYTE GROWTH FACTOR CORRELATES WITH SERUM GLUCOSE LEVELS IN HYPERTENSIVE SUBJECTS. Nephrology Dialysis Transplantation. 38(Supplement_1).

Jelaković, Bojan, Lana Gellineo, Ana Jelaković, et al.. (2023). Renal Denervation in the Treatment of Resistant Hypertension and Difficult-to-Control Hypertension – Consensus Document of the Croatian Hypertension League – Croatian Society of Hypertension, Croatian Cardiac Society, Croatian Endovascular Initiative, Croatian Society for Diabetes and Metabolic Diseases, Croatian Renal Association, and Croatian Society of Family Physicians of the Croatian Medical Association. Vascular Health and Risk Management. Volume 19. 805–826.

Čarni, Andraž, Renata Ćušterevska, Tetiana Dziuba, et al.. (2023). Different Ecological Niches of Poisonous Aristolochia clematitis in Central and Marginal Distribution Ranges—Another Contribution to a Better Understanding of Balkan Endemic Nephropathy. Plants. 12(17). 3022–3022. 1 indexed citations

10.

Weber, Thomas, Michael Doumas, Christian Delles, et al.. (2023). The Hypertension Excellence Centre programme of the European Society of Hypertension – current status, activities and reshaping for the future. Blood Pressure. 32(1). 2269431–2269431. 1 indexed citations

11.

Borghi, Claudio, Konstantinos Tsioufis, Enrico Agabiti‐Rosei, et al.. (2020). Nutraceuticals and blood pressure control: a European Society of Hypertension position document. Journal of Hypertension. 38(5). 799–812. 50 indexed citations

12.

Kotsis, Vasilios, Jens Jordan, Stella Stabouli, et al.. (2019). Cardiovascular, renal and liver protection with novel antidiabetic agents beyond blood glucose lowering in type 2 diabetes: consensus article from the European Society of Hypertension Working Group on Obesity, Diabetes and the High-risk Patient. Journal of Hypertension. 38(3). 377–386. 6 indexed citations

13.

Premužić, Vedran, Vanja Ivković, Sandra Karanović, et al.. (2018). Arterial Stiffness in Balkan Endemic Nephropathy, an Environmental Form of Aristolochic Acid Nephropathy. Frontiers in Cardiovascular Medicine. 5. 166–166. 4 indexed citations

14.

Jelaković, Bojan, Maja Baretić, Maja Čikeš, et al.. (2017). Practical guidelines for diagnosing arterial hypertension of the Croatian Society of Hypertension of Croatian Medical Association and the Working Group on Hypertension of the Croatian Cardiac Society. Cardiologia Croatica. 12(11-12). 413–451.

15.

Karanović, Sandra, Vanja Ivković, Ana Jelaković, et al.. (2017). Serum urates are not associated with albuminuria in pre-hypertensive patients and newly diagnosed hypertensive patients. Cardiologia Croatica. 12(3). 51–51.

16.

Palatini, Paolo, Enrico Agabiti Rosei, Edoardo Casiglia, et al.. (2016). Management of the hypertensive patient with elevated heart rate. Journal of Hypertension. 34(5). 813–821. 64 indexed citations

17.

Božina, Tamara, et al.. (2013). Interaction of Genetic Risk Factors Confers Increased Risk for Metabolic Syndrome: The Role of Peroxisome Proliferator-Activated Receptor γ. Genetic Testing and Molecular Biomarkers. 18(1). 32–40. 6 indexed citations

18.

Jelaković, Bojan, et al.. (2010). Epidemiologija hipertenzije, moždanog udara i infarkta miokarda u Hrvatskoj. 16. 102–107. 3 indexed citations

19.

Grollman, Arthur P., Shinya Shibutani, Masaaki Moriya, et al.. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proceedings of the National Academy of Sciences. 104(29). 12129–12134. 448 indexed citations breakdown →

20.

Dika, Živka, Ivan Pećin, & Bojan Jelaković. (2007). Epidemiologija arterijske hipertenzije u Hrvatskoj i svijetu. University of Zagreb University Computing Centre (SRCE). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact